{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:56:26Z","timestamp":1791878186932,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404540"],"award-info":[{"award-number":["82404540"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"publisher","award":["ZNYB2023007"],"award-info":[{"award-number":["ZNYB2023007"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijid.2026.109023","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:51:23Z","timestamp":1785858683000},"page":"109023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative efficacy and safety of antibacterial regimens for severe Stenotrophomonas maltophilia infections: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"171","author":[{"given":"Suyu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1809-4984","authenticated-orcid":false,"given":"Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijid.2026.109023_bib0001","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/microorganisms10122506","article-title":"Stenotrophomonas maltophilia epidemiology, resistance characteristics, and clinical outcomes: understanding of the recent three years' trends","volume":"10","author":"Hafiz","year":"2022","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.ijid.2026.109023_bib0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/antibiotics10101226","article-title":"Antimicrobial treatment strategies for Stenotrophomonas maltophilia: a focus on novel therapies","volume":"10","author":"Gibb","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2026.109023_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.109023_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1556\/030.2026.02883","article-title":"Stenotrophomonas maltophilia infections: current status on first-line therapy and other treatment options","volume":"73","author":"Charoenlap","year":"2026","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.ijid.2026.109023_bib0006","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ijid.2026.109023_bib0007","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ijid.2026.109023_bib0008","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ijid.2026.109023_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijid.2026.109023_bib0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.ijid.2026.109023_bib0011","article-title":"Healthcare-associated Stenotrophomonas maltophilia bacteraemia: retrospective evaluation of treatment and outcome","volume":"13","author":"Tuncel","year":"2021","journal-title":"Cureus J Med Sci"},{"key":"10.1016\/j.ijid.2026.109023_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13613-023-01144-7","article-title":"Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study","volume":"13","author":"Chen","year":"2023","journal-title":"Annals of Intensive Care"},{"key":"10.1016\/j.ijid.2026.109023_bib0013","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4328\/ACAM.22890","article-title":"Levofloxacin as a potential substitute for trimethoprim-sulfamethoxazole in Stenotrophomonas maltophilia infections: a retrospective cohort study","volume":"16","author":"Ozalp","year":"2025","journal-title":"Ann Clin Anal Med"},{"key":"10.1016\/j.ijid.2026.109023_bib0014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jgar.2017.09.015","article-title":"Sulfamethoxazole\/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections","volume":"12","author":"Watson","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.ijid.2026.109023_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1179\/1120009X12Z.00000000022","article-title":"Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections","volume":"24","author":"Tek\u00e7e","year":"2012","journal-title":"J Chemother"},{"issue":"2","key":"10.1016\/j.ijid.2026.109023_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab644","article-title":"Trimethoprim-sulfamethoxazole versus levofloxacin for Stenotrophomonas maltophilia infections: a retrospective comparative effectiveness study of electronic health records from 154 US hospitals","volume":"9","author":"Sarzynski","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/10600280231166413","article-title":"Comparison of doxycycline or minocycline to sulfamethoxazole-trimethoprim for treatment of Stenotrophomonas maltophilia pneumonia","volume":"58","author":"Alhayani","year":"2024","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.01682-13","article-title":"Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?","volume":"58","author":"Cho","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2026.109023_bib0019","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jac\/dkaf024","article-title":"Comparison of trimethoprim-sulfamethoxazole versus minocycline monotherapy for treatment of Stenotrophomonas maltophilia pneumonia","volume":"80","author":"Graves","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2026.109023_bib0020","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/10600280231201850","article-title":"Trimethoprim\/sulfamethoxazole vs minocycline for the treatment of nonurinary monomicrobial Stenotrophomonas maltophilia infections in hospitalized patients","volume":"58","author":"Hevia","year":"2024","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.ijid.2026.109023_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106367","article-title":"Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim\/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy","volume":"58","author":"Junco","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2026.109023_bib0022","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.2147\/IDR.S416678","article-title":"The activities of antimicrobials against Stenotrophomonas maltophilia isolates and evaluation of clinical outcomes among treatment regimens in patients with Stenotrophomonas maltophilia infections: a retrospective multicenter cohort study","volume":"16","author":"Boonmee","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2026.109023_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jgar.2024.05.016","article-title":"Trimethoprim-sulfamethoxazole versus levofloxacin for the treatment of Stenotrophomonas maltophilia infections: a multicentre cohort study","volume":"38","author":"Almangour","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0024","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s15010-025-02695-6","article-title":"Comparison of clinical and safety outcomes in patients with Stenotrophomonas maltophilia bacteremia: a trimethoprim\/sulfamethoxazole versus levofloxacin monotherapy","volume":"54","author":"Chen","year":"2026","journal-title":"Infection"},{"issue":"11","key":"10.1016\/j.ijid.2026.109023_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00788-19","article-title":"Clinical and microbiologic outcomes in patients with monomicrobial Stenotrophomonas maltophilia infections","volume":"63","author":"Nys","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2026.109023_bib0026","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo","year":"2023","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.ijid.2026.109023_bib0027","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0028","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13613-020-00715-2","article-title":"Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections","volume":"10","author":"De Pascale","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"14","key":"10.1016\/j.ijid.2026.109023_bib0029","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3390\/jcm14144819","article-title":"Evaluation of adverse events associated with the sulfamethoxazole\/trimethoprim combination drug","volume":"14","author":"Sagawa","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.109023_bib0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2013.232","article-title":"Fluid management for the prevention and attenuation of acute kidney injury","volume":"10","author":"Prowle","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.ijid.2026.109023_bib0031","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/jac\/dkac262","article-title":"Trimethoprim-associated hyperkalaemia: a systematic review and meta-analysis","volume":"77","author":"Far\u00e9","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2026.109023_bib0032","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cmi.2024.11.035","article-title":"Oral switch vs. continued intravenous antibiotic therapy in patients with bacteraemia and sepsis: a systematic review and meta-analysis","volume":"31","author":"Li","year":"2025","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:51:15Z","timestamp":1791816675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226006582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S1201971226006582"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109023","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of antibacterial regimens for severe Stenotrophomonas maltophilia infections: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109023"}}